Senior Principal Scientist, Lab Head, Immunology, Cell Therapy
Roche
Summary
The Department of Immunology Discovery at Genentech is excited to announce an opportunity for a Senior Principal Scientist, Lab Head, to lead a research group focused on designing next-generation cell therapies to treat autoimmune diseases.
Job description
The Opportunity
The Department of Immunology Discovery at Genentech is excited to announce an opportunity for a Senior Principal Scientist, Lab Head, to lead a research group focused on designing next-generation cell therapies to treat autoimmune diseases.
The successful candidate will lead a highly productive research team, integrating efforts across cross-functional teams to identify new targets and therapeutic hypotheses, and to advance transformative therapeutics from preclinical studies into early clinical development. The ideal candidate will have a deep understanding of cellular immunology principles and pathways relevant to the biology of autoimmune disease, including but not limited to inflammatory bowel disease, multiple sclerosis, lupus and chronic obstructive pulmonary disease. Excellent communication skills are essential to facilitate fruitful collaborations with colleagues across a diverse array of departments, including computational biology, proteomics and tissue genomics, drug development, early clinical development, and translational medicine.
Key Responsibilities
- Lead and manage a highly-productive research team
- Generate high-quality, original research that advances our understanding of autoimmune disease
- Contribute directly to the initiation and advancement of novel pipeline projects
- Play a critical role within cross-functional teams evaluating external business development opportunities to accelerate our cell therapy pipeline
Who You Are
- PhD and postdoctoral training in Immunology, Cell Biology or related field
- A minimum of 10 years post-PhD experience with a record of high-impact publications (preprints considered), patents, and/or a proven track record advancing therapeutic candidates from pipeline entry to early clinical development and recognized as an established researcher in their field
- Demonstrated expertise in cellular immunology and a deep understanding of pathways and immune cell types that contribute to autoimmune disease
- Outstanding leadership and a collaborative spirit, with a proven track record of working with multidisciplinary teams
- Excellent written and verbal communication skills, with the ability to communicate complex scientific concepts to multidisciplinary audiences
- Exceptional critical thinking skills, a commitment to rigorous experimental design and creative problem-solving, and a demonstrated ability to use data-driven insights to guide scientific decisions
Preferred Qualifications
- Expertise in both B cell and T cell biology
- Experience engineering, modifying, and functionally evaluating human immune cells
- Experience working with mouse models, including humanized models
Requirements
- PhD and postdoctoral training in Immunology, Cell Biology or related field
- Minimum of 10 years post-PhD experience
- Record of high-impact publications, patents, and/or proven track record advancing therapeutic candidates from pipeline entry to early clinical development
- Recognized as an established researcher in their field
- Demonstrated expertise in cellular immunology
- Deep understanding of pathways and immune cell types that contribute to autoimmune disease
- Outstanding leadership and collaborative spirit
- Proven track record of working with multidisciplinary teams
- Excellent written and verbal communication skills
- Exceptional critical thinking skills
- Commitment to rigorous experimental design and creative problem-solving
- Demonstrated ability to use data-driven insights to guide scientific decisions
Benefits
- Relocation benefits
- Discretionary annual bonus
Company overview
Roche is a Swiss multinational healthcare company and a global pioneer in pharmaceuticals and diagnostics, founded in 1896 and headquartered in Basel, Switzerland. As the world's largest biotech company and the fifth-largest pharmaceutical company by revenue, Roche operates through two primary divisions: Pharmaceuticals and Diagnostics. The company is renowned for its leadership in personalized healthcare, combining strengths in both drug development and diagnostic testing to deliver tailored treatments for patients. Roche maintains a strong focus on oncology, immunology, infectious diseases, ophthalmology, and central nervous system disorders, with a portfolio that includes over 30 medicines on the World Health Organization's Model Lists of Essential Medicines. The company owns significant subsidiaries including Genentech, Chugai Pharmaceuticals, Ventana Medical Systems, and Foundation Medicine. With approximately 103,000 employees worldwide and operations in over 100 countries, Roche has established itself as a leader in cancer treatments globally while maintaining a robust pipeline of innovative therapies and diagnostic solutions. The company's commitment to sustainability has been recognized through ten consecutive years as Group Leader in the Dow Jones Sustainability Indices within the Pharmaceuticals, Biotechnology & Life Sciences Industry.